Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

{
  "signal_id": "7f0bce07-74f4-fab1-75c7-57a148cdfdc0",
  "signal_type": "news",
  "signal_subtype": "leaves",
  "detected_at": "2026-07-24T21:33:00+00:00",
  "company": {
    "name": "GE HealthCare",
    "domain": "gehealthcare.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/07/24/3333132/0/en/Securities-Fraud-Investigation-Into-GE-HealthCare-Technologies-Inc-GEHC-Continues-Shareholders-Who-Lost-Money-Urged-To-Contact-The-Law-Offices-of-Frank-R-Cruz.html",
    "title": "Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz",
    "contact": "Jay Saccaro",
    "excerpt": "LOS ANGELES, July 24, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC ) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On April 29, 2026, GE HealthCare reported its financial results for the first quarter of 2026. Among other items, GE HealthCare reported adjusted earnings per share of $0.99 and cut its full-year 2026 adjusted EPS guidance to a range of $4.80 to $5.00, down from prior guidance of $4.95 to $5.15. During the associated earnings call, management disclosed “ profit performance in the first quarter . . . was impacted by a recall associated with a PDx supplier ” and that “ [y]ear-over-year margin performance was also impacted by declines in PCS and the PDx supplier issue. ” On this news, the price of GE HealthCare shares declined by $9.01 per share, or 13.2%, to close at $59.49 per share on April 29, 2026. On July 23, 2026, the Company announced its Chief Financial Officer, Jay Saccaro, will step ‌down from his role, and the Company will appoint an interim CFO while it searches for a permanent replacement...",
    "summary": "Jay Saccaro will step down from his role as Chief Financial Officer of GE HealthCare Technologies Inc.",
    "planning": true,
    "image_url": "https://ml.globenewswire.com/Resource/Download/778ea178-25d1-48a3-9141-a162814899d4",
    "job_title": "Chief Financial Officer",
    "confidence": 0.95,
    "published_at": "2026-07-24T21:33:00Z",
    "job_title_tags": [
      "directors",
      "finance"
    ],
    "article_sentence": "On July 23, 2026, the Company announced its Chief Financial Officer, Jay Saccaro, will step ‌down from his role, and the Company will appoint an interim CFO while it searches for a permanent replacement."
  }
}

curl https://signals.autobound.ai/v1/signals/7f0bce07-74f4-fab1-75c7-57a148cdfdc0 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"gehealthcare.com","limit":20}'